Mylan will pay $465 million over another EpiPen issue. Credit: getty images Mylan will pay the Department of Justice $465 million in a settlement over its pricing and classification of the EpiPen ...
The deal sparked some early confusion over the price tag. Initial coverage from Crain's Chicago Business reported an $82.5 ...
Mylan (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE™ (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day), the ...
Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...
After weeks of controversy, the Centers for Medicare and Medicaid Services formally blamed Mylan Pharmaceuticals for misclassifying EpiPen with the Medicaid Drug Rebate Program. Under the program, ...
Mylan CEO Heather Bresch survived an ouster attempt by angry shareholders. Heather Bresch is willing to participate in a high-profile industry conference this week, but not testify before Congress — ...
Source: Teva Pharmaceutical via Facebook. What: Shares of Mylan, a branded-drug developer that is alsoa large player in the generic drug market, surged by 22% in April, according to data from S&P ...
In a rare appearance since the EpiPen controversy flared this summer, Mylan Pharmaceuticals CEO Heather Bresch accepted “full responsibility” Thursday for the price hikes that caused national outrage.
Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...
Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...
Mylan NV finalized a $465 million settlement with the U.S. Justice Department. The settlement resolves claims the pharmaceutical company overcharged the government for its EpiPen emergency allergy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results